David Tougeron, Professor at Poitiers University Hospital, shared on LinkedIn:
“It is a great pleasure to share our last international IMMUNODIG study published in JITC showing that immune-related adverse events are not correlated with IO efficacy in dMMR/MSI-H digestive tumors.”
Title: Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy
Authors: David Tougeron, Charles Kauffmann, Margherita Ambrosini, Olayide Boussari, Sara Lonardi, Frank A. Sinicrope, Marwan Fakih, Michael J. Overman, Elena Elez, Anthony Turpin, Marie Decraecker, Antoine Hollebecque, Simon Pernot, Thibault Mazard, Marie Dutherage, Romain Cohen, Francesco Sclafani, Mohamed Ben Abdelghani, Thomas Aparicio, Clélia Coutzac, Vincent Hautefeuille, Marie Muller, Chiara Cremolini, Rosine Guimbaud, Julien Taieb, Filippo Pietrantonio, Raphael Olivier, Emily Alouani
More posts featuring David Tougeron on OncoDaily.